Overexpression of folate binding protein α is one of the mechanism explaining the adaptation of HT29 cells to high concentration of methotrexate
Authors:
- Jean-Louis GuéantJGJean-Louis Guéant
- Charles AdjallaCACharles Adjalla
- Céline ChéryCCCéline Chéry
- Renée HatierRHRenée Hatier
- Farès NamourFNFarès Namour
- 1 October 2001
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 171 (2) , 139-145
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- CARRIER-MEDIATED MEMBRANE TRANSPORT OF FOLATES IN MAMMALIAN CELLSAnnual Review of Nutrition, 1999
- Symposium on the Subcellular Compartmentation of Folate MetabolismThe Journal of Nutrition, 1996
- Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cellsBiochemical Pharmacology, 1995
- Distinguishing between Folate Receptor-α-mediated Transport and Reduced Folate Carrier-mediated Transport in L1210 Leukemia CellsJournal of Biological Chemistry, 1995
- The methotrexate story: A paradigm for development of cancer chemotherapeutic agentsAdvances in Enzyme Regulation, 1994
- Methotrexate transport in the human intestine: Evidence for heterogeneityBiochemical Pharmacology, 1992
- Potocytosis: Sequestration and Transport of Small Molecules by CaveolaeScience, 1992
- Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNABiochemistry, 1989
- Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol.Journal of Clinical Investigation, 1989
- The cellular pharmacology of methotrexatePharmacology & Therapeutics, 1985